Xiangxue Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Xiangxue Pharmaceutical Co Ltd with three other
companies in this sector in China:
Haisco Pharmaceutical Group Co Ltd
sales of 1.86 billion Chinese Renmimbi [US$295.85 million]
of which 99%
Guangxi Wuzhou Zhongheng Group, Ltd.
(2.05 billion Chinese Renmimbi [US$326.17 million]
of which 93%
was Pharmaceutical Segment), and
Zhejiang Hisoar Pharmaceutical Co. Ltd
(2.31 billion Chinese Renmimbi [US$368.02 million]
of which 56%
was Pharmatheutical Industry).
During the year ended December of 2017, sales at
Xiangxue Pharmaceutical Co Ltd were 2.19 billion Chinese Renmimbi (US$348.64 million).
increase of 17.5%
versus 2016, when the company's sales were 1.86 billion Chinese Renmimbi.
Sales of Beverage saw an increase
that was more than double the company's growth rate: sales were up
38.1% in 2017, from
93.36 million Chinese Renmimbi to 128.97 million Chinese Renmimbi.
Xiangxue Pharmaceutical Co Ltd also saw significant increases in sales in
Chinese Herbal Medicines (up 30.1% to 811.60 million Chinese Renmimbi)
Not all segments of Xiangxue Pharmaceutical Co Ltd experienced an increase in sales in 2017:
sales of Pharmaceutical Manufacturing fell 16.5% to 470.36 million Chinese Renmimbi.
Xiangxue Pharmaceutical Co Ltd also experienced decreases in sales in
Medical Apparatus and Instruments (down 13.3% to 18.20 million Chinese Renmimbi)